Literature DB >> 34542202

A mechanistic insight into the biological activities of urolithins as gut microbial metabolites of ellagitannins.

Seyyed Hossein Hasheminezhad1, Motahareh Boozari1, Mehrdad Iranshahi2, Omid Yazarlu3, Amirhossein Sahebkar2, Maede Hasanpour2, Milad Iranshahy1.   

Abstract

Urolithins are the gut metabolites produced from ellagitannin-rich foods such as pomegranates, tea, walnuts, as well as strawberries, raspberries, blackberries, and cloudberries. Urolithins are of growing interest due to their various biological activities including cardiovascular protection, anti-inflammatory activity, anticancer properties, antidiabetic activity, and antiaging properties. Several studies mostly based on in vitro and in vivo experiments have investigated the potential mechanisms of urolithins which support the beneficial effects of urolithins in the treatment of several diseases such as Alzheimer's disease, type 2 diabetes mellitus, liver disease, cardiovascular disease, and various cancers. It is now obvious that urolithins can involve several cellular mechanisms including inhibition of MDM2-p53 interaction, modulation of mitogen-activated protein kinase pathway, and suppressing nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) activity. Antiaging activity is the most appealing and probably the most important property of urolithin A that has been investigated in depth in recent studies, owing to its unique effects on activation of mitophagy and mitochondrial biogenesis. A recent clinical trial showed that urolithin A is safe up to 2,500 mg/day and can improve mitochondrial biomarkers in elderly patients. Regarding the importance of mitochondria in the pathophysiology of many diseases, urolithins merit further research especially in clinical trials to unravel more aspects of their clinical significance. Besides the nutritional value of urolithins, recent studies proved that urolithins can be used as pharmacological agents to prevent or cure several diseases. Here, we comprehensively review the potential role of urolithins as new therapeutic agents with a special focus on the molecular pathways that have been involved in their biological effects. The pharmacokinetics of urolithins is also included.
© 2021 John Wiley & Sons Ltd.

Entities:  

Keywords:  Antiaging; Cancer; Inflammation; Mitophagy; Urolithin

Mesh:

Substances:

Year:  2021        PMID: 34542202     DOI: 10.1002/ptr.7290

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  8 in total

Review 1.  Antiaging agents: safe interventions to slow aging and healthy life span extension.

Authors:  Ji-Kai Liu
Journal:  Nat Prod Bioprospect       Date:  2022-05-09

2.  Gut Metabolite Urolithin A Inhibits Osteoclastogenesis and Senile Osteoporosis by Enhancing the Autophagy Capacity of Bone Marrow Macrophages.

Authors:  Huaqiang Tao; Yunxia Tao; Chen Yang; Wenming Li; Wei Zhang; Xueyan Li; Ye Gu; Yujing Hong; Huilin Yang; Yu Liu; Xing Yang; Dechun Geng
Journal:  Front Pharmacol       Date:  2022-05-12       Impact factor: 5.988

3.  Design, synthesis, and biological evaluation of novel urolithins derivatives as potential phosphodiesterase II inhibitors.

Authors:  Long Tang; Guoqiang Song; Yajing Wang; Jianchun Jiang; Ziheng Zhuang; Ying Tan; Yan Xia; Xianfeng Huang; Xiaoqing Feng
Journal:  Sci Rep       Date:  2021-12-10       Impact factor: 4.379

Review 4.  Coenzyme Q10 deficiency can be expected to compromise Sirt1 activity.

Authors:  James J DiNicolantonio; Mark F McCarty; James H O'Keefe
Journal:  Open Heart       Date:  2022-03

5.  Urolithin A as a Potential Drug for the Treatment of Spinal Cord Injuries: A Mechanistic Study Using Network Pharmacology Approaches.

Authors:  Chao Mao; HaoPeng Luan; ShuTao Gao; WeiBin Sheng
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-22       Impact factor: 2.650

6.  Urolithin A Attenuates Hyperuricemic Nephropathy in Fructose-Fed Mice by Impairing STING-NLRP3 Axis-Mediated Inflammatory Response via Restoration of Parkin-Dependent Mitophagy.

Authors:  Cong Zhang; Yingying Song; Liang Chen; Peng Chen; Ming Yuan; Yan Meng; Qi Wang; Guohua Zheng; Zhenpeng Qiu
Journal:  Front Pharmacol       Date:  2022-06-15       Impact factor: 5.988

7.  Urolithins Modulate the Viability, Autophagy, Apoptosis, and Nephrin Turnover in Podocytes Exposed to High Glucose.

Authors:  Milena Kotewicz; Mirosława Krauze-Baranowska; Agnieszka Daca; Agata Płoska; Sylwia Godlewska; Leszek Kalinowski; Barbara Lewko
Journal:  Cells       Date:  2022-08-09       Impact factor: 7.666

8.  Lactococcus garvieae FUA009, a Novel Intestinal Bacterium Capable of Producing the Bioactive Metabolite Urolithin A from Ellagic Acid.

Authors:  Haoyu Mi; Shu Liu; Yang Hai; Guang Yang; Jing Lu; Fuxiang He; Yaling Zhao; Mengjie Xia; Xiaoyue Hou; Yaowei Fang
Journal:  Foods       Date:  2022-08-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.